In Memoriam

In memoriam: Michael Waterfield

Swarnali  Roy
May 6, 2024

Michael Derek Waterfield, a British biochemist and a pioneer in the cancer research field died on May 11, 2023, at the age of 82, the American Society for Biochemistry and Molecular Biology learned recently. He had been an ASBMB member since 1996. 

Portrait of Michael Waterfield
Michael Waterfield

Born in Hampshire, United Kingdom on May 14, 1941, Waterfield completed his undergraduate studies in biochemistry at Brunel University, London. He then earned his Ph.D. in protein chemistry and enzymology from King’s College Hospital Medical School, London. He moved to Harvard Medical School in 1967 to pursue postdoctoral studies in which he quantified the method of sequential degradation of proteins and peptides. 

Following a second postdoctoral stint with American biologist Leroy Hood at the California Institute of Technology on first gas phase protein sequencer and upon receiving a fellowship from the American Heart Foundation, Waterfield joined the Imperial Cancer Research Fund, or ICRF, in London in 1972. His research group and technical team at ICRF were the first to implement a first-generation state-of-the-art protein sequence database. 

Waterfield developed his interest in studying growth factor receptors. Using highly purified fibroblast‐derived growth factor, or FDGF, he reported a structural resemblance between platelet‐derived growth factor and FDGF. His group also found the relationship between epidermal growth factor receptor, or EGFR, and oncogenes and was the first to sequence protein kinase C. Waterfield was instrumental in groundbreaking cancer research in ICRF, and his findings led to development of anti-cancer drugs targeting the EGF receptor family. 

In 1986, Waterfield joined the Ludwig Institute for Cancer Research at University College London as director. He developed his interest in the critical growth regulatory enzyme phosphatidylinositol 3-kinase, or PI3K, and started working on its sequence. He also founded a biotech company Piramed where six drugs targeting PI3K enzymes were clinically approved. 

Waterfield had more than 151 publications in journals such as Nature, Science, and the Journal of Biological Chemistry, with more than 39,352 citations. He also broadened research horizons in cancer proteomics by opening a proteomics lab at University College London. He retired in 2008. 

Waterfield was a fellow of the Royal Society, the Royal College of Pathologists and the Academy of Medical Sciences U.K.  He was recognized with the Royal Society's Buchanan Medal in 2002 for his exceptional skill in protein biochemistry and the Biology and Biochemistry in Belgium Leader Award in 2023. 

He is survived by his wife, Sal, and his daughters, Lucy and Rosie.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Swarnali  Roy

Swarnali Roy is a postdoctoral researcher in the Laboratory of Bioorganic Chemistry at the National Institute of Diabetes and Digestive and Kidney Diseases. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Feature

ASBMB undergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Member News

Honors for Gagna and Sundquist

July 7, 2025

Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.